These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19722284)

  • 41. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
    Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
    PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding.
    Scobie HM; Young JA
    PLoS One; 2006 Dec; 1(1):e99. PubMed ID: 17183731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
    Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
    Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
    Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The protective antigen component of anthrax toxin forms functional octameric complexes.
    Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA
    J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acid induced unfolding of anthrax protective antigen.
    Gupta PK; Kurupati RK; Chandra H; Gaur R; Tandon V; Singh Y; Maithal K
    Biochem Biophys Res Commun; 2003 Nov; 311(1):229-32. PubMed ID: 14575718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-cell voltage clamp measurements of anthrax toxin pore current.
    Wolfe JT; Krantz BA; Rainey GJ; Young JA; Collier RJ
    J Biol Chem; 2005 Nov; 280(47):39417-22. PubMed ID: 16183642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anthrax toxin protective antigen--insights into molecular switching from prepore to pore.
    Bann JG
    Protein Sci; 2012 Jan; 21(1):1-12. PubMed ID: 22095644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding.
    Ramey JD; Villareal VA; Ng C; Ward SC; Xiong JP; Clubb RT; Bradley KA
    Biochemistry; 2010 Aug; 49(34):7403-10. PubMed ID: 20690680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptors of anthrax toxin and cell entry.
    van der Goot G; Young JA
    Mol Aspects Med; 2009 Dec; 30(6):406-12. PubMed ID: 19732789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exchange characteristics of calcium ions bound to anthrax protective antigen.
    Gao-Sheridan S; Zhang S; Collier RJ
    Biochem Biophys Res Commun; 2003 Jan; 300(1):61-4. PubMed ID: 12480521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that histidine protonation of receptor-bound anthrax protective antigen is a trigger for pore formation.
    Wimalasena DS; Janowiak BE; Lovell S; Miyagi M; Sun J; Zhou H; Hajduch J; Pooput C; Kirk KL; Battaile KP; Bann JG
    Biochemistry; 2010 Aug; 49(33):6973-83. PubMed ID: 20672855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atomic structure of anthrax protective antigen pore elucidates toxin translocation.
    Jiang J; Pentelute BL; Collier RJ; Zhou ZH
    Nature; 2015 May; 521(7553):545-9. PubMed ID: 25778700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dark sides of capillary morphogenesis gene 2.
    Deuquet J; Lausch E; Superti-Furga A; van der Goot FG
    EMBO J; 2012 Jan; 31(1):3-13. PubMed ID: 22215446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure of the Anthrax Protective Antigen D425A Dominant Negative Mutant Reveals a Stalled Intermediate State of Pore Maturation.
    Scott H; Huang W; Andra K; Mamillapalli S; Gonti S; Day A; Zhang K; Mehzabeen N; Battaile KP; Raju A; Lovell S; Bann JG; Taylor DJ
    J Mol Biol; 2022 May; 434(9):167548. PubMed ID: 35304125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
    Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
    Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-Specific Labeling and
    Gonti S; Westler WM; Miyagi M; Bann JG
    Biochemistry; 2021 Mar; 60(9):643-647. PubMed ID: 33428379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.